{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T10:33:29Z","timestamp":1781951609828,"version":"3.54.5"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"41","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,10]]},"abstract":"<jats:p>\n                    The optimal timing for initiating oral anticoagulation in patients with atrial fibrillation (AF) following acute ischemic stroke (AIS) remains uncertain in specific subgroups and real-world settings. This study evaluates the association between early (\u22642 days) versus later (&gt;2 days) oral anticoagulation initiation and short-term clinical outcomes in patients with AF and mild to moderate AIS. We conducted a retrospective cohort study using the TriNetX global research network. Adult patients (\u226518 years) diagnosed with both AF and AIS (National Institutes of Health Stroke Scale 0\u201315) between January 2010 and February 2025 were included. Patients were categorized into early and later initiation groups based on treatment start time. The primary outcome was a 30-day composite of tissue plasminogen activator (tPA) use, intracranial hemorrhage (ICH), and all-cause mortality. Propensity score matching (1:1) was used to adjust for baseline characteristics. Cox regression and Kaplan\u2013Meier methods were used for analysis. A total of 5240 matched patients (2620 per group) were included. Early anticoagulation initiation was associated with a significantly lower risk of the primary composite outcome (hazard ratio (HR): 0.43; 95% CI: 0.30\u20130.60;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). Each component of the composite outcome was also significantly reduced in the early group. Subgroup analyses showed consistent results across male sex, age over 75 years, paroxysmal AF, patients with heart failure, coronary artery disease, hypertension, and different anticoagulants (apixaban and rivaroxaban), though some subgroups had wide confidence intervals due to small sample sizes. Negative control outcomes, landmark analysis, and E-value analysis supported the robustness of the findings. In patients with mild to moderate AIS and AF, early initiation of oral anticoagulation within 2 days was associated with a significantly lower 30-day composite of tPA use, ICH, and all-cause mortality compared to the later initiation group. These findings support the safety and potential benefit of early anticoagulation initiation, though further randomized controlled trials are needed to confirm these results and inform clinical guidelines.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000045180","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T05:03:21Z","timestamp":1760331801000},"page":"e45180","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Early versus late oral anticoagulation after mild to moderate AIS in AF patients: Insights from real-world data"],"prefix":"10.1097","volume":"104","author":[{"given":"Jheng-Yan","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Nutrition, Chi Mei Medical Center, Tainan, Taiwan"},{"name":"Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Li","family":"Kao","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, E-Da Hospital, I-Shou University, Kaohsiung City, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Chuan","family":"Hung","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Chi Mei Medical Center, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Public Health, College of Medicine, National Cheng Kung University, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1723-828X","authenticated-orcid":false,"given":"Yu-Min","family":"Lin","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Chi Mei Medical Center, Chiali, Tainan, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"1 Pt C","key":"R1-20260113","doi-asserted-by":"crossref","first-page":"102181","DOI":"10.1016\/j.cpcardiol.2023.102181","article-title":"Atrial fibrillation and stroke: state-of-the-art and future directions.","volume":"49","author":"Elsheikh","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"R2-20260113","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.3390\/jcm12185784","article-title":"Atrial fibrillation and ischemic stroke despite oral anticoagulation.","volume":"12","author":"Galea","year":"2023","journal-title":"J Clin Med"},{"key":"R3-20260113","doi-asserted-by":"crossref","first-page":"e022638","DOI":"10.1161\/JAHA.121.022638","article-title":"Ischemic stroke severity and mortality in patients with and without atrial fibrillation.","volume":"11","author":"Vinding","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"R4-20260113","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/23969873231168367","article-title":"The contribution of competing mechanisms in stroke despite anticoagulation in patients with atrial fibrillation.","volume":"8","author":"Herlekar","year":"2023","journal-title":"Eur Stroke J"},{"key":"R5-20260113","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000316886","article-title":"Pathophysiological determinants of worse stroke outcome in atrial fibrillation.","volume":"30","author":"Tu","year":"2010","journal-title":"Cerebrovasc Dis"},{"issue":"4 Suppl","key":"R6-20260113","doi-asserted-by":"crossref","first-page":"352S","DOI":"10.1378\/chest.108.4_Supplement.352S","article-title":"Antithrombotic therapy in atrial fibrillation.","volume":"108","author":"Laupacis","year":"1995","journal-title":"Chest"},{"key":"R7-20260113","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"R8-20260113","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.3390\/jcm11174981","article-title":"Early anticoagulation in patients with acute ischemic stroke due to atrial fibrillation: a systematic review and meta-analysis.","volume":"11","author":"Palaiodimou","year":"2022","journal-title":"J Clin Med"},{"key":"R9-20260113","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1161\/01.STR.0000254600.92975.1f","article-title":"Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials.","volume":"38","author":"Paciaroni","year":"2007","journal-title":"Stroke"},{"key":"R10-20260113","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1161\/STROKEAHA.107.510321","article-title":"Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study.","volume":"39","author":"Paciaroni","year":"2008","journal-title":"Stroke"},{"key":"R11-20260113","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS.","volume":"18","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"key":"R12-20260113","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association.","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"key":"R13-20260113","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1177\/23969873241251931","article-title":"Timing of oral anticoagulants initiation for atrial fibrillation after acute ischemic stroke: a systematic review and meta-analysis.","volume":"9","author":"Palaiodimou","year":"2024","journal-title":"Eur Stroke J"},{"key":"R14-20260113","article-title":"Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial","author":"Werring","journal-title":"Lancet"},{"issue":"Suppl 1","key":"R15-20260113","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.4103\/sja.SJA_543_18","article-title":"The STROBE guidelines.","volume":"13","author":"Cuschieri","year":"2019","journal-title":"Saudi J Anaesth"},{"key":"R16-20260113","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/jama.2015.13480","article-title":"The propensity score.","volume":"314","author":"Haukoos","year":"2015","journal-title":"JAMA"},{"key":"R17-20260113","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value.","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"R18-20260113","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1017\/cjn.2022.268","article-title":"Timing of anticoagulation after acute ischemic stroke in patients with atrial fibrillation.","volume":"50","author":"Alrohimi","year":"2023","journal-title":"Can J Neurol Sci"},{"key":"R19-20260113","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1161\/STROKEAHA.116.015770","article-title":"Prediction of early recurrent thromboembolic event and major bleeding in patients with acute stroke and atrial fibrillation by a risk stratification schema: the ALESSA score study.","volume":"48","author":"Paciaroni","year":"2017","journal-title":"Stroke"},{"key":"R20-20260113","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/jnnp-2018-318890","article-title":"Early versus late anticoagulation for ischaemic stroke associated with atrial fibrillation: multicentre cohort study.","volume":"90","author":"Wilson","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R21-20260113","doi-asserted-by":"crossref","first-page":"e007034","DOI":"10.1161\/JAHA.117.007034","article-title":"Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with non-vitamin-K oral anticoagulants (RAF-NOACs) study.","volume":"6","author":"Paciaroni","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"R22-20260113","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.122.060666","article-title":"Early versus delayed non-vitamin K antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation (TIMING): a registry-based randomized controlled noninferiority study.","volume":"146","author":"Oldgren","year":"2022","journal-title":"Circulation"},{"key":"R23-20260113","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1161\/STROKEAHA.121.036695","article-title":"Practical \u201c1-2-3-4-day\u201d rule for starting direct oral anticoagulants after ischemic stroke with atrial fibrillation: combined hospital-based cohort study.","volume":"53","author":"Kimura","year":"2022","journal-title":"Stroke"},{"key":"R24-20260113","doi-asserted-by":"crossref","first-page":"e0212354","DOI":"10.1371\/journal.pone.0212354","article-title":"Rivaroxaban administration after acute ischemic stroke: the RELAXED study.","volume":"14","author":"Yasaka","year":"2019","journal-title":"PLoS One"},{"key":"R25-20260113","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/1747493016632239","article-title":"Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: the SAMURAI-nonvalvular atrial fibrillation (NVAF) study.","volume":"11","author":"Arihiro","year":"2016","journal-title":"Int J Stroke"},{"key":"R26-20260113","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1056\/NEJMoa2303048","article-title":"Early versus later anticoagulation for stroke with atrial fibrillation.","volume":"388","author":"Fischer","year":"2023","journal-title":"N Engl J Med"},{"key":"R27-20260113","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/STROKEAHA.115.008891","article-title":"Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibrillation: effect of anticoagulation and its timing: the RAF study.","volume":"46","author":"Paciaroni","year":"2015","journal-title":"Stroke"},{"key":"R28-20260113","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jamaneurol.2024.1450","article-title":"Early vs late anticoagulation in minor, moderate, and major ischemic stroke with atrial fibrillation: post hoc analysis of the ELAN randomized clinical trial.","volume":"81","author":"Goeldlin","year":"2024","journal-title":"JAMA Neurol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T20:03:12Z","timestamp":1768334592000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":28,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045180","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"2025-06-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}